Evidence map›Paper›PMID 27568546›Full record

ArticleCell metabolism2016

SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a Regulation.

Manuel Roqueta-Rivera, Ryan M Esquejo, Peter E Phelan, Katalin Sandor, Bence Daniel, Fabienne Foufelle, Jun Ding, Xiaoman Li, Sepideh Khorasanizadeh, Timothy F Osborne

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. The Many Faces of SetDB1.Epigenomes · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Inhibition of triglyceride metabolism-associated enhancers alters lipid deposition during adipocyte differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Manuel Roqueta-RiveraSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA.
Ryan M EsquejoSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA.
Peter E PhelanSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA.
Katalin SandorSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA.
Bence DanielSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA.
Fabienne FoufelleINSERM, UMR-S 872, Centre de Recherches des Cordeliers, 75006 Paris, France; Université Pierre et Marie Curie-Paris, 75005 Paris, France.
Jun DingBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Boulevard, Orlando, FL 32827, USA.
Xiaoman LiBurnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 6900 Lake Nona Boulevard, Orlando, FL 32827, USA.
Sepideh KhorasanizadehSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA.
Timothy F OsborneSanford Burnham Prebys Medical Discovery Institute, 6400 Sanger Road, Orlando, FL 32827, USA. Electronic address: tosborne@sbpdiscovery.org.
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of Central Florida · USInserm · FR

Funding

Sterol Regulatory Element Binding Proteins in Regulation of Lipid MetabolismR01HL048044 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI OSBORNE, TIMOTHY F · 1993 to 2017
$7.3M
American Heart Association-American Stroke Association 12POST12040390NHLBI NIH HHS R01 HL048044
6 · The paper itself

Abstract

Transcriptional and chromatin regulations mediate the liver response to nutrient availability. The role of chromatin factors involved in hormonal regulation in response to fasting is not fully understood. We have identified SETDB2, a glucocorticoid-induced putative epigenetic modifier, as a positive regulator of GR-mediated gene activation in liver. Insig2a increases during fasting to limit lipid synthesis, but the mechanism of induction is unknown. We show Insig2a induction is GR-SETDB2 dependent. SETDB2 facilitates GR chromatin enrichment and is key to glucocorticoid-dependent enhancer-promoter interactions. INSIG2 is a negative regulator of SREBP, and acute glucocorticoid treatment decreased active SREBP during refeeding or in livers of Ob/Ob mice, both systems of elevated SREBP-1c-driven lipogenesis. Knockdown of SETDB2 or INSIG2 reversed the inhibition of SREBP processing. Overall, these studies identify a GR-SETDB2 regulatory axis of hepatic transcriptional reprogramming and identify SETDB2 as a potential target for metabolic disorders with aberrant glucocorticoid actions.

Indexed as

AnimalsChromatinDexamethasoneEnhancer Elements, GeneticFeeding BehaviorGene Expression RegulationGene Knockdown TechniquesGenetic LociGlucocorticoidsHistone-Lysine N-MethyltransferaseHistonesLipid MetabolismLiverLysineMaleMembrane ProteinsChromatinDexamethasoneGlucocorticoidsHistone-Lysine N-MethyltransferaseHistonesInsig2 protein, mouseLysineMembrane ProteinsReceptors, GlucocorticoidRNA, MessengerSterol Regulatory Element Binding Protein 1fasting liverglucocorticoid receptorinsig2SETDB2SREBP

Identifiers

PMID27568546
PMCPMC5023502
OpenAlexW2510826424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.